NCT06873880 Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients
| NCT ID | NCT06873880 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Tartu |
| Condition | Chronic Kidney Disease Requiring Chronic Dialysis |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-02-10 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study looks at how measurements of body composition from Bioelectrical Impedance Analysis (BIA) and estimates of kidney function (eGFR) can be applied together to better assess the health of people on hemodialysis. Many dialysis patients struggle with malnutrition, muscle loss, and fluid imbalances, but current assessment methods rely on unsophisticated tests and observations. By combining BIA and eGFR, this study aims to provide a more accurate and non-invasive way to monitor nutrition and overall health, which could lead to better treatment decisions and improved patient outcomes.
Eligibility Criteria
Inclusion Criteria: Chronic kidney disease Hemodialysis for at least 6 months Exclusion Criteria: Pregnancy Lactation Major second pathology Pacemaker Recent surgery
Contact & Investigator
Alastair Forbes, MD
STUDY DIRECTOR
University of Tartu
Frequently Asked Questions
Who can join the NCT06873880 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Kidney Disease Requiring Chronic Dialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06873880 currently recruiting?
Yes, NCT06873880 is actively recruiting participants. Contact the research team at anumbasit.08@gmail.com for enrollment information.
Where is the NCT06873880 trial being conducted?
This trial is being conducted at Tartu, Estonia.
Who is sponsoring the NCT06873880 clinical trial?
NCT06873880 is sponsored by University of Tartu. The principal investigator is Alastair Forbes, MD at University of Tartu. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.